Press Releases

IR Mobile SiteTear sheetEmail pagePDF viewPrint viewRSS FeedsEmail AlertSocial Media Sharing


Year:
Notify me when new press releases are posted to this site.
Press Releases
5/23/2013Cubist to Present at Jefferies 2013 Global Healthcare Conference
5/19/2013Cubist Achieves Top Biotech Ranking in Globe 100 List
5/08/2013Cubist to Present at Bank of America Merrill Lynch 2013 Healthcare Conference
5/07/2013FDA Grants Fast Track Designation for Cubist’s Late-Stage Antibiotic Candidate
4/18/2013Cubist Pharmaceuticals Reports First Quarter 2013 Financial Results
4/11/2013Cubist to Announce First Quarter 2013 Financial Results on Thursday, April 18th, 2013
4/09/2013Cubist Pharmaceuticals and the New England Patriots Radio Network Honor Lynn, Massachusetts Biology Teacher
3/11/2013Cubist Obtains Remaining Rights to Ceftolozane from Astellas
3/04/2013Cubist Announces Appointment of Michael Tomsicek to Chief Financial Officer
2/28/2013FDA Grants QIDP and Fast Track Designations for Cubist’s Late-Stage Antibiotic Candidates
2/27/2013Cubist Pharmaceuticals to Present at Cowen and Company 33rd Annual Health Care Conference
2/25/2013Cubist Announces Exclusive Option to Acquire Adynxx
1/29/2013Cubist to Present at February Investor Conferences
1/23/2013Cubist Reports Fourth Quarter and Full Year 2012 Financial Results
1/08/2013Cubist to Appoint Tom DesRosier as Senior Vice President, Chief Legal Officer and Secretary
1/07/2013Cubist Announces Full-Year 2012 Revenues and Provides Business Update
12/21/2012Cubist Submits ENTEREG Supplemental NDA
12/06/2012FDA Grants QIDP Designation to Two Cubist Phase 3 Antibiotic Candidates
12/03/2012Cubist to Present at December Investor Conference
11/05/2012Cubist Named One of “Top Places to Work” by the Boston Globe for Fifth Consecutive Year
11/02/2012Cubist to Present at November Investor Conferences
10/31/2012Cubist Enrolls 1st Patient in Phase 3 CB-5945 Program for the Treatment of Opioid-Induced Constipation
10/18/2012Cubist Increases Revenue 18% to $238 Million in the Third Quarter
10/16/2012Cubist to Feature Antibiotic Development Program at Inaugural IDWeek Annual Meeting
10/05/2012Cubist Announces Management Change
9/06/2012Cubist to Feature Antibiotic Development Programs at 52nd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
9/05/2012Cubist and the New England Patriots Radio Network Team Up to Recognize Innovative Science Teachers
9/04/2012Cubist Appoints Patrick Vink as Senior Vice President and General Manager of International Business
8/29/2012Cubist to Present at September Investor Conference
7/30/2012Cubist to Present at August Investor Conference
7/19/2012Cubist Increases Revenue 30% to $231 Million in the Second Quarter
7/12/2012Cubist to Announce Second Quarter 2012 Financial Results on Thursday, July 19th, 2012
7/12/2012Cubist Pharmaceuticals Enrolls 1st Patient in Phase 3 Trial for Therapy to Treat Clostridium Difficile-Associated Diarrhea
More Press Releases...
 
 Source: SNL Financial LC 

Copyright 2013, © SNL Financial LC  Terms of Use